Gene · 411
Papers1,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomics and transcriptomics reveal new molecular mechanism of vibriosis resistance in fish. | Front Immunol | 2022 | 36304468 | PubTator, text mining | PubMed |
| Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets? | Antioxidants (Basel) | 2022 | 36290744 | PubTator, text mining | PubMed |
| Abstracts from the 11th International Conference for Healthcare and Medical Students (ICHAMS) : Virtual. 10-12 February 2022. | BMC Proc | 2022 | 36289474 | PubTator, text mining | PubMed |
| Global genomic analysis of microbial biotransformation of arsenic highlights the importance of arsenic methylation in environmental and human microbiomes. | Comput Struct Biotechnol J | 2022 | 36284711 | PubTator, text mining | PubMed |
| Plug-and-Display Photo-Switchable Systems on Plant Virus Nanoparticles. | BioTech (Basel) | 2022 | 36278561 | PubTator, text mining | PubMed |
| Mucopolysaccharidosis-Plus Syndrome: Report on a Polish Patient with a Novel VPS33A Variant with Comparison with Other Described Patients. | Int J Mol Sci | 2022 | 36232726 | PubTator, text mining | PubMed |
| Genome-Resolved Metagenomics and Metatranscriptomics Reveal that Aquificae Dominates Arsenate Reduction in Tengchong Geothermal Springs. | Environ Sci Technol | 2022 | 36227700 | PubTator, text mining | PubMed |
| Increased ocular wall thickness and decreased globe volume in children with mucopolysaccharidosis type VI. | Diagn Interv Radiol | 2022 | 36218154 | PubTator, text mining | PubMed |
| Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. | Nat Med | 2022 | 36216932 | PubTator, text mining | PubMed |
| Early enzyme replacement therapy prevents dental and craniofacial abnormalities in a mouse model of mucopolysaccharidosis type VI. | Front Physiol | 2022 | 36213247 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia. | Front Nutr | 2022 | 36185699 | PubTator, text mining | PubMed |
| Delivering gene therapy for mucopolysaccharide diseases. | Front Mol Biosci | 2022 | 36172050 | PubTator, text mining | PubMed |
| O-Sulfation disposition of curcumin and quercetin in SULT1A3 overexpressing HEK293 cells: the role of arylsulfatase B in cellular O-sulfation regulated by transporters. | Food Funct | 2022 | 36156668 | PubTator, text mining | PubMed |
| Ocular Drug Delivery: Advancements and Innovations. | Pharmaceutics | 2022 | 36145679 | PubTator, text mining | PubMed |
| Xylan Prebiotics and the Gut Microbiome Promote Health and Wellbeing: Potential Novel Roles for Pentosan Polysulfate. | Pharmaceuticals (Basel) | 2022 | 36145372 | PubTator, text mining | PubMed |
| Mucopolysaccharidoses and the blood-brain barrier. | Fluids Barriers CNS | 2022 | 36117162 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors. | Front Genet | 2022 | 36110213 | PubTator, text mining | PubMed |
| A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives. | Transl Neurodegener | 2022 | 36109823 | PubTator, text mining | PubMed |
| Twenty years of Colombian experience with enzymatic screening in patients with features of mucopolysaccharidosis. | JIMD Rep | 2022 | 36101826 | PubTator, text mining | PubMed |
| Genetic association between circulating selenium level and the risk of schizophrenia in the European population: A two-sample Mendelian randomization study. | Front Nutr | 2022 | 36082036 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/411/papers?page=12